Items where Author is "Brancaccio, A."

2009

Huze, C. and Bauche, S. and Richard, P. and Chevessier, F. and Goillot, E. and Gaudon, K. and Ben Ammar, A. and Chaboud, A. and Grosjean, I. and Lecuyer, H. -A. and Bernard, V. and Rouche, A. and Alexandri, N. and Kuntzer, T. and Fardeau, M. and Fournier, E. and Brancaccio, A. and Ruegg, M. A. and Koenig, J. and Eymard, B. and Schaeffer, L. and Hantai, D.. (2009) Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. American Journal of Human Genetics, 85 (2). pp. 155-167.

2006

Scotton, P. and Bleckmann, D. and Stebler, M. and Sciandra, F. and Brancaccio, A. and Meier, T. and Stetefeld, J. and Ruegg, M. A.. (2006) Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin. Journal of Biological Chemistry, 281 (48). pp. 36835-36845.

1998

Brancaccio, A. and Jeno, P. and Engel, J.. (1998) A single disulfide bridge (Cys182-Cys264) is crucial for alpha-dystroglycan N-terminal domain stability. Annals of the New York Academy of Sciences, Vol. 857. pp. 228-231.

Gesemann, M. and Brancaccio, A. and Schumacher, B. and Ruegg, M. A.. (1998) Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. Journal of Biological Chemistry, 273 (1). pp. 600-605.

1996

Gesemann, M. and Cavalli, V. and Denzer, A. J. and Brancaccio, A. and Schumacher, B. and Ruegg, M. A.. (1996) Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron, Vol. 16, H. 4. pp. 755-767.

1995

Brancaccio, A. and Ruegg, M. A. and Engel, J.. (1995) Cloning and sequencing of mouse skeletal muscle alpha-dystroglycan. Matrix biology, Vol. 14, H. 8. pp. 681-685.